Hypotriglyceridemias/hypolipidemias.
Martínez-Hervás S, Real-Collado JT, Ascaso-Gimilio JF.
Clin Investig Arterioscler. 2021 May;33 Suppl 2:63-68. doi: 10.1016/j.arteri.2020.12.011.
Hypocholesterolemia.
Moutzouri E, Elisaf M, Liberopoulos EN.
Curr Vasc Pharmacol. 2011 Mar;9(2):200-12. doi: 10.2174/157016111794519354.
Hypolipidemia.
Malloy MJ, Kane JP.
Med Clin North Am. 1982 Mar;66(2):469-84. doi: 10.1016/s0025-7125(16)31431-6.
[Familial hypo beta-lipoproteinemia].
Tohdoh Y, Mabuchi H.
Ryoikibetsu Shokogun Shirizu. 1998;(19 Pt 2):29-32.
Hypobetalipoproteinemia and abetalipoproteinemia.
Welty FK.
Curr Opin Lipidol. 2014 Jun;25(3):161-8. doi: 10.1097/MOL.0000000000000072.
Neuroacanthocytosis syndromes.
Jung HH, Danek A, Walker RH.
Orphanet J Rare Dis. 2011 Oct 25;6:68. doi: 10.1186/1750-1172-6-68.
[Neuroacanthocytosis update].
Ichiba M, Nakamura M, Sano A.
Brain Nerve. 2008 Jun;60(6):635-41.
New pathogenic mutation of chorea-acanthocytosis.
Garrido-Fernández A, Santos-Lasaosa S, Bellosta-Diago E, Sáchez-Valiente S.
Neurologia (Engl Ed). 2020 Mar;35(2):73-74. doi: 10.1016/j.nrl.2018.03.012. Epub 2018 May 8.
Low LDL cholesterol-Friend or foe?
Hartz J, Hegele RA, Wilson DP.
J Clin Lipidol. 2019 May-Jun;13(3):367-373. doi: 10.1016/j.jacl.2019.05.006. Epub 2019 May 16.
[Familial hypobetalipoproteinemia].
Kinoshita M.
Nihon Rinsho. 2001 Mar;59 Suppl 3:254-7.
